Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




AI Automates Detection of Mitral Regurgitation on Echocardiograms for Minimally Invasive Procedure

By HospiMedica International staff writers
Posted on 23 Aug 2024

Mitral valve regurgitation is the most common but often missed heart valve disorder. Out of the four valves in the heart for facilitating blood movement throughout the body, the mitral valve, situated on the heart's left side, fails to close properly in some individuals, leading to blood flowing backward, a condition known as mitral valve regurgitation. This issue hampers blood circulation and may evolve into more severe complications such as shortness of breath, arrhythmia, and heart failure. Accurately determining the severity of this condition is crucial to deciding whether patients might adopt a watch-and-wait strategy or require immediate intervention. Researchers have now developed an artificial intelligence (AI) program to detect the presence and severity of mitral valve regurgitation from echocardiograms that could help identify patients for a minimally invasive procedure or surgery.

To develop the new program, investigators at Smidt Heart Institute at Cedars-Sinai (Los Angeles, CA, USA) utilized over 58,000 transthoracic echocardiograms—a type of ultrasound imaging used to evaluate heart conditions, including mitral regurgitation. The effectiveness of this program was evaluated using echocardiograms from 1,800 patients at Cedars-Sinai and an additional 915 from Stanford Healthcare. The findings, published in Circulation, show that the AI model demonstrated high accuracy in identifying moderate to severe cases of mitral valve regurgitation. After analyzing videos from more than 50,000 echocardiogram studies, the deep learning model effectively identified the most relevant and important videos for evaluating the severity of mitral regurgitation.

“This could improve how we identify patients with mitral regurgitation, which is becoming more prevalent in our aging population, and to personalize treatment even more so than we already do,” said Raj Makkar, MD, associate director of the Smidt Heart Institute, where the team has also performed more than 1,500 robotic mitral valve repairs with a near 100% success rates.

Related Links:
Smidt Heart Institute

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Mobile Patient Lift
Golvo 9000
New
HF Stationary X-Ray Machine
TR20G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.